Latest news

A syngeneic orthotopic EMT6 breast mouse model for preclinical immuno-oncology testing of novel anti-cancer strategies

07 / 09 / 2020

Because of metastatic development of the disease, among other characteristics, and regardless of survival data, breast cancer was shown to be particularly difficult to treat. However, metastases as well as resistance to therapies continue to be a great challenge and the development of new therapeutic strategies is increasingly necessary.